Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma
- PMID: 21109934
Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma
Abstract
The overexpression of fibroblast growth factor receptor (FGFR) 4 has been reported in various human cancers, but it has not been studied in pancreatic ductal adenocarcinoma (PDAC) or its precursor lesion, pancreatic intraepithelial neoplasia (PanIN). Moreover, there is controversy as to whether FGFR4 has a mitogenic role in carcinogenesis or other functions. Therefore, the expression and roles of FGFR4 in pancreatic cancer were investigated. Immunohistochemical staining was performed using an anti-FGFR4 antibody in PDAC and PanIN cases. The expression levels of FGFR4 mRNA and protein were investigated in PDAC cell lines by qRT-PCR and Western blot, respectively. Changes were analyzed in cell morphology, proliferation, migration, invasion and attachment in PDAC cell lines with or without the stimulation of FGFR4 by FGF19, as a known specific ligand. The changes in mRNA levels associated with transformation and tumorigenesis as a result of FGF19 administration were also evaluated. FGFR4 was expressed in 39 of 53 PDAC cases (73.6%) and its expression tended to be related to longer overall survival (P=0.068). Moreover, it was frequently expressed in high-grade PanIN lesions [10 of 11 lesions (90.9%)], whereas it was hardly expressed in low-grade PanIN lesions [1 of 10 lesions (10.0%)] (P=0.0003). FGFR4 stimulation of PDAC cells resulted in significantly increased cell adhesion to laminin and fibronectin (P<0.05) and decreased cell migration (P<0.05). The results of PCR array analysis indicated that this was a result of up-regulation of the integrin α4 family. In contrast, cell morphology or proliferation in PDAC cells was not affected. We showed that FGFR4 expression is markedly increased in high-grade PanIN and PDAC compared with that in normal and low-grade PanIN, and that FGFR4 stimulation by FGF19 of PDAC cells contributes to tumor suppression by increasing cell adhesion to extracellular matrix.
Similar articles
-
Loss of heterozygosity status of D9S105 marker is associated with downregulation of Krüppel-like factor 4 expression in pancreatic ductal adenocarcinoma and pancreatic intraepithelial lesions.Pancreatology. 2011;11(1):30-42. doi: 10.1159/000322990. Epub 2011 Mar 16. Pancreatology. 2011. PMID: 21412023
-
The biological features of PanIN initiated from oncogenic Kras mutation in genetically engineered mouse models.Cancer Lett. 2013 Oct 1;339(1):135-43. doi: 10.1016/j.canlet.2013.07.010. Epub 2013 Jul 22. Cancer Lett. 2013. PMID: 23887057
-
Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues.J Pathol. 2012 Apr;226(5):723-34. doi: 10.1002/path.3017. Epub 2012 Jan 17. J Pathol. 2012. PMID: 21984419
-
Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.Semin Radiat Oncol. 2005 Oct;15(4):254-64. doi: 10.1016/j.semradonc.2005.04.001. Semin Radiat Oncol. 2005. PMID: 16183479 Review.
-
Pancreatic intraepithelial neoplasia revisited and updated.Pancreatology. 2009;9(1-2):45-54. doi: 10.1159/000178874. Epub 2008 Dec 12. Pancreatology. 2009. PMID: 19077454 Review.
Cited by
-
FGFR4: A promising therapeutic target for breast cancer and other solid tumors.Pharmacol Ther. 2020 Oct;214:107590. doi: 10.1016/j.pharmthera.2020.107590. Epub 2020 May 31. Pharmacol Ther. 2020. PMID: 32492514 Free PMC article. Review.
-
An FGFR/AKT/SOX2 Signaling Axis Controls Pancreatic Cancer Stemness.Front Cell Dev Biol. 2020 May 7;8:287. doi: 10.3389/fcell.2020.00287. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32457900 Free PMC article.
-
Dissecting the Role of the FGF19-FGFR4 Signaling Pathway in Cancer Development and Progression.Front Cell Dev Biol. 2020 Feb 20;8:95. doi: 10.3389/fcell.2020.00095. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32154250 Free PMC article. Review.
-
Turning towards nonimmunoreactive tumors: Evaluation of cancer-associated fibroblasts enables prediction of the immune microenvironment and treatment sensitivity in pancreatic cancer.Comput Struct Biotechnol J. 2022 Jul 20;20:3911-3923. doi: 10.1016/j.csbj.2022.07.029. eCollection 2022. Comput Struct Biotechnol J. 2022. PMID: 35950187 Free PMC article.
-
Deciphering role of FGFR signalling pathway in pancreatic cancer.Cell Prolif. 2019 May;52(3):e12605. doi: 10.1111/cpr.12605. Epub 2019 Apr 3. Cell Prolif. 2019. PMID: 30945363 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous